The Judges Scientific dividend grew 25% last year. Can it keep going?

Our writer does not think the Judges Scientific dividend growth story is too good to be true. So why won’t he be buying the shares for now?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A pastel colored growing graph with rising rocket.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The business model of Judges Scientific (LSE: JDG) is simple yet successful. It buys up small and medium-sized specialist instrument makers, offers them the benefits of centralised support and largely lets them get on with what they do best. In some ways, it is reminiscent of the business model Warren Buffett uses at Berkshire Hathaway. But while Berkshire does not pay anything out to shareholders, the Judges Scientific dividend has been growing quickly.

Last year, it increased by 25%. That is only the latest in a series of double-digit percentage increases.

Created using TradingView

The future looks bright

I think Judges might only just be getting going. It has proven its business model and is now scaling it up. Its fast-growing revenues pay testament to this.

Created using TradingView

The company has also proven that it can grow profits, not just revenues.

That is important from an income perspective because ultimately to pay dividends, a company needs to be making money. Not only is Judges profitable, it is also cash generative. Free cash flows have been growing healthily.

Created using TradingView

Dividend could keep rising

I think that is good news when it comes to the Judges Scientific dividend. Already, it is well-covered. Indeed, last year the dividend was covered more than four times by earnings. That means that Judges has substantial scope to keep increasing the dividend at a good clip even if earnings are flat.

In fact, though, I expect earnings to grow over the long term. Judges can help acquired companies improve their sales organically, thanks to its wide customer base and marketing prowess. The company also continues to grow through acquisition. Last year saw organic revenue growth of 15% and the company acquired several firms.

The rate of increase may slow over time as the baseline gets bigger (although that remains to be seen). But I see no reason to expect the company to stop growing dividends.

It has the cash to do so and I think dividend growth has been a key part of the investment case for the company thus far. Changing that suddenly could hurt the share price.

Why I’m not buying

There are risks. They could prevent growth, or lead to the dividend falling.

One would be if the firm overstretches itself trying to fund larger acquisitions that do not turn out well. Another is the emergence of competitors aping Judges’ successful business model, making it harder for the business to find attractively priced acquisitions.

Still, I like the company and would happily own the shares. But I do not like the valuation at all.

The price-to-earnings ratio of 80 is way too high for my tastes. That high valuation has also served to depress the dividend yield. Despite a growing payout, the yield is just 0.8%.

So unless the valuation becomes more attractive, I will not be buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Judges Scientific Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

3 ISA strategies to consider in 2025

This Fool believes that when it comes to building wealth through an ISA portfolio, there are three basic approaches worth…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

7 top tips to consider for an £88k passive income!

A regular monthly investment in trusts or shares could yield a stunning passive income in retirement. Here's how an investor…

Read more »

Stack of one pound coins falling over
Investing Articles

2 penny shares I think could shine in 2025

I have my eye on a few penny shares, as I'm thinking that the year ahead could turn out to…

Read more »

Investing Articles

2 ISA strategies for success in 2025

The ISA is a great vehicle for our investments, sheltering our returns from tax and providing us with the opportunity…

Read more »

Investing Articles

Here’s how an investor could start building a £10,000 second income for £180 per month in 2025

Our writer illustrates how an investor could put under £200 each month into shares and build a long-term five-figure passive…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’m finding bargain shares to buy for 2025!

Our writer takes a fairly simply approach when it comes to hunting for cheap shares to buy for his portfolio.…

Read more »

A graph made of neon tubes in a room
Investing Articles

Up 262%! This lesser-known energy company is putting other S&P 500 stocks to shame

Our writer delves into the rationale behind the parabolic growth of this under-the-radar S&P 500 energy company. The reason isn’t…

Read more »

Investing Articles

Just released: December’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »